These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 34066231)

  • 1. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2.
    Dimeglio C; Milhes M; Loubes JM; Ranger N; Mansuy JM; Trémeaux P; Jeanne N; Latour J; Nicot F; Donnadieu C; Izopet J
    Viruses; 2021 May; 13(5):. PubMed ID: 34066231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France.
    Dimeglio C; Miedougé M; Loubes JM; Mansuy JM; Izopet J
    Rev Med Virol; 2021 Sep; 31(5):1-8. PubMed ID: 33713504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.
    Li CX; Noreen S; Zhang LX; Saeed M; Wu PF; Ijaz M; Dai DF; Maqbool I; Madni A; Akram F; Naveed M; Li JH
    Biomed Pharmacother; 2022 Feb; 146():112550. PubMed ID: 34959116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence, spread and characterisation of the SARS-CoV-2 variant B.1.640 circulating in France, October 2021 to February 2022.
    Picard G; Fournier L; Maisa A; Grolhier C; Chent S; Huchet-Kervalla C; Sudour J; Pretet M; Josset L; Behillil S; Schaeffer J; ; ; ;
    Euro Surveill; 2023 Jun; 28(22):. PubMed ID: 37261732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    Galloway SE; Paul P; MacCannell DR; Johansson MA; Brooks JT; MacNeil A; Slayton RB; Tong S; Silk BJ; Armstrong GL; Biggerstaff M; Dugan VG
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):95-99. PubMed ID: 33476315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France.
    Dimeglio C; Miedougé M; Loubes JM; Mansuy JM; Izopet J
    J Infect; 2021 May; 82(5):186-230. PubMed ID: 33535066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
    Dimeglio C; Loubes JM; Mansuy JM; Izopet J
    J Infect; 2021 Mar; 82(3):414-451. PubMed ID: 33129838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic.
    El-Shabasy RM; Nayel MA; Taher MM; Abdelmonem R; Shoueir KR; Kenawy ER
    Int J Biol Macromol; 2022 Apr; 204():161-168. PubMed ID: 35074332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
    Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing.
    Hart WS; Maini PK; Thompson RN
    Elife; 2021 Apr; 10():. PubMed ID: 33899740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics.
    Jacob JJ; John Fletcher G; Monisha Priya T; Veeraraghavan B; Mutreja A
    Indian J Med Microbiol; 2021; 39(4):417-422. PubMed ID: 34454775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.
    Avila-Ponce de León U; Avila-Vales E; Huang K
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.
    Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN
    Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies.
    Bian L; Gao F; Zhang J; He Q; Mao Q; Xu M; Liang Z
    Expert Rev Vaccines; 2021 Apr; 20(4):365-373. PubMed ID: 33851875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.